Article
Τumor-informed vs Tumor-naïve
Liquid biopsies are a rapidly evolving diagnostic technology with numerous labs offering commercially available tests today. Most labs have taken an approach of cell-free (cfDNA)
July 3, 2023 10:36 am
Genomics
Read More »
Article
Case Study: VEXAS Syndrome
Background VEXAS syndrome is a disease with inflammatory and hematologic (blood) manifestations. The syndrome is caused by mutations in the UBA1 gene affecting the Met41 residue of
June 8, 2022 11:20 am
Genomics
ASH22 Posters
GTC presented abstracts at ASH 2022 GTC’s posters from 2022 Convention of American Society of Hematology are now available to be downloaded. Please reach out
December 13, 2022 10:00 am
Genomics
ASH21 Posters
In partnership with Anthology Diagnostics and Key Genomics, GTC presented four abstracts at ASH 2021 GTC’s posters from 2021 Convention of American Society of Hematology
December 14, 2021 9:32 pm
Article
GTC scientists contribute to major study published in Journal of Clinical Oncology: Prediction of outcome in CLL patients
GTC scientists collaborate with the NIH on a study just published in the Journal of Clinical Oncology. The publication is titled: Prediction of outcome in
October 8, 2020 10:45 am
Article
Genomic Testing Cooperative Aims to Expand Clinical, Commercial NGS Access With Co-Op Model
Jul 23, 2020 | John Gilmore NEW YORK – As part of plans to establish a country-wide network of labs for minimizing the cost of
August 26, 2020 9:20 am
Genomics
John Theurer Cancer Center/RCCA collaborate with GTC to internalize proprietary NGS DNA and RNA testing
John Theurer Cancer Center to Establish Next Generation Sequencing Laboratory for Precision Genomic Profiling of Cancers, Adapting Testing Developed for DNA and RNA IRVINE, Calif.
May 27, 2020 4:00 am
Genomics
GTC was featured in the Orange County Business Journal again
GTC featured in the Orange County Business Journal on February 3, 2020
February 26, 2020 11:00 am
Genomics
GTC was honored to be featured in the Orange County Business Journal
GTC featured in the Orange County Business Journal on September 30, 2019 [Click image to enlarge]
October 16, 2019 10:24 am
Innovation
Do not Accept partial results about PH-Like Acute Lymphoblastic Leukemia
Distinguishing PH-like acute lymphoblastic leukemia (ALL) from other types of ALL relies on full evaluation of the molecular abnormalities in the leukemic cells. Order GTC
October 1, 2019 10:16 pm